Cargando…
Modulation of AMPK Significantly Alters Uveal Melanoma Tumor Cell Viability
INTRODUCTION: Uveal melanoma (UM) responds poorly to targeted therapies or immune checkpoint inhibitors. Adenosine monophosphate-activated protein kinase (AMPK) is a pivotal serine/threonine protein kinase that coordinates vital processes such as cell growth. Targeting AMPK pathway, which represents...
Autores principales: | Deliktas, Ozge, Gedik, M. Emre, Koc, Irem, Gunaydin, Gurcan, Kiratli, Hayyam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10614466/ https://www.ncbi.nlm.nih.gov/pubmed/37647867 http://dx.doi.org/10.1159/000533806 |
Ejemplares similares
-
Current Management of Conjunctival Melanoma Part 2: Treatment and Future Directions
por: Koç, İrem, et al.
Publicado: (2020) -
Current Management of Conjunctival Melanoma Part 1: Clinical Features, Diagnosis and Histopathology
por: Koç, İrem, et al.
Publicado: (2020) -
Uveal Melanoma: Current Trends in Diagnosis and Management
por: Tarlan, Berçin, et al.
Publicado: (2016) -
In vivo Confocal Microscopy in Differentiating Ipilimumab-Induced Anterior Uveitis from Metastatic Uveal Melanoma
por: Kiratli, Hayyam, et al.
Publicado: (2016) -
Photodynamic Therapy for the Treatment and Diagnosis of Cancer–A Review of the Current Clinical Status
por: Gunaydin, Gurcan, et al.
Publicado: (2021)